IVROInVitro International

About InVitro International (IVRO)

InVitro International (IVRO) is a Diagnostics & Research company headquartered in Placentia, CA, United States whose shares trade over-the-counter on the OTCQB tier.

More than 2 decades old developer & global marketer of non-animal testing methods specifically targeting eye & skin irritation as well as possible corrosive chemicals/formulations/waste streams. We provide laboratory testing services as well as training to support sale of kits for customer in-house performance of our assays.

Products and services

The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its products direct to customers, independent partner laboratories, and agents in the United States, Europe, Latin America and Asia. It also conducts laboratory testing for those customers who prefer not to conduct their own tests.

IVRO key facts

Ticker symbol

IVRO

Market tier

OTCQB

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Placentia, CA, United States

Country of incorporation

US

Year of incorporation

1985

Employees

6

Estimated market cap

$1.28M (as of May 12, 2025)

Shares outstanding

22,759,809

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

9/30

Latest filing

Quarterly Report (Mar 31, 2025)

InVitro International leadership

• W. Richard Ulmer — CEO, President
• Cathy Lynn Richmond — CFO
• Jessica M. Lockett — Legal Counsel

Explore more: Diagnostics & Research stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with I